VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 225 filers reported holding VERACYTE INC in Q4 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078,494 | -67.2% | 48,298 | -62.6% | 0.00% | -100.0% |
| Q2 2023 | $3,289,909 | +327.0% | 129,168 | +273.8% | 0.00% | – |
| Q1 2023 | $770,532 | -51.8% | 34,553 | -48.8% | 0.00% | -100.0% |
| Q4 2022 | $1,600,186 | +267.9% | 67,433 | +208.4% | 0.00% | – |
| Q2 2022 | $435,000 | -55.0% | 21,866 | -37.7% | 0.00% | – |
| Q1 2022 | $967,000 | +27.9% | 35,100 | +91.2% | 0.00% | – |
| Q4 2021 | $756,000 | +156.3% | 18,359 | +189.3% | 0.00% | – |
| Q3 2021 | $295,000 | -22.4% | 6,347 | -33.3% | 0.00% | – |
| Q2 2021 | $380,000 | -47.9% | 9,511 | -29.9% | 0.00% | – |
| Q1 2021 | $729,000 | -70.4% | 13,571 | -73.1% | 0.00% | -100.0% |
| Q4 2020 | $2,466,000 | +409.5% | 50,392 | +238.2% | 0.00% | – |
| Q3 2020 | $484,000 | +131.6% | 14,902 | +85.0% | 0.00% | – |
| Q2 2020 | $209,000 | -57.4% | 8,055 | -79.4% | 0.00% | -100.0% |
| Q4 2018 | $491,000 | – | 39,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |